2型糖尿病患者并发下肢动脉粥样硬化的影响因素分析及列线图模型构建

doi:10.13481/j.1671-587X.20260322

Abstract

Abstract:

Objective To discuss the risk factors in the type 2 diabetes mellitus （T2DM） patients complicated with low extremity atherosclerosis （LEAD）， and to establish a nomogram prediction model， so as to provide clinical basis for early identification of high-risk populations and formulation of intervention strategies. Methods The clinical data of 269 patients with T2DM were collected. The patients were divided into LEAD group （n=197） and non-LEAD group （n=72） according to whether they had concurrent LEAD. Univariate and multivariate Logistic regression analyses were used to analyze the risk factors of T2DM patients complicated with LEAD； the nomogram was used to construct a risk prediction model； the Bootstrap method （B=1 000） was used for internal validation； the receiver operating characteristic （ROC） curve， calibration curve， and decision curve analysis （DCA） were used to comprehensively evaluate the predictive performance of the model. Results The univariate analysis results showed that compared with non-LEAD group， the age， disease duration， fasting plasma glucose （FBG）， body mass index（BMI）， triglyceride （TG）， smoking history， and history of hypertension in the patients in LEAD group had statistically significant differences （P<0.05）. The multivariate Logistic regression analysis results showed that patients’ age ［odds ratio （OR）=1.082， 95% confidence interval （CI）： 1.039-1.127， P<0.001］， BMI（OR=1.287， 95%CI： 1.154-1.436， P<0.001）， and FBG （OR=1.159， 95%CI： 1.043-1.288， P=0.006） were the independent risk factors for T2DM complicated with LEAD. The Bootstrap internal consistency index （C-index） was 0.841 （95%CI： 0.793-0.890）， indicating that the model had good discriminative performance. The calibration curve analysis results showed that the Brier score was 0.138， and the predicted probability was highly consistent with the actual observed probability， indicating good calibration of the model. The DCA standardized net benefit value ranged from 0.2 to 0.8， indicating that the model had a significant net benefit advantage. Conclusion High BMI level is an important influencing factor for the T2DM patients complicated with LEAD. The constructed nomogram risk model based on the risk factors has good predictive performance.

Key words: Body mass index, Type 2 diabetes mellitus, Lower extremity atherosclerosis, Prediction model, Risk factors

CLC Number:

R587.1

Jing YU,Yinzhuo HUANG,Zhongwei ZHOU,Yuxin XIE,Qian MAO. Analysis on influencing factors in type 2 diabetes mellitus patients complicated with lower limb atherosclerosis and construction of nomogram model[J].Journal of Jilin University(Medicine Edition), 2026, 52(3): 806-812.

Figures/Tables 8

Tab.1

Tab.2

Tab.3

Tab.4

Fig. 1

Fig. 2

Fig. 3

Fig. 4

References 26

[1]	HANCHINAL S S， SHIVANAL A B， KAMNI S， et al. Efficacy of a pocket pulse oximeter and a digital pulse oximeter as screening tools for type 2 diabetes patients with asymptomatic lower extremity arterial disease［J］. Maedica， 2021， 16（3）： 362-367.
[2]	JOOSTEN M M， PAI J K， BERTOIA M L， et al. Associations between conventional cardiovascular risk factors and risk of peripheral artery disease in men［J］. JAMA， 2012， 308（16）： 1660-1667.
[3]	DINESH SHAH A， LANGENBERG C， RAPSOMANIKI E， et al. Type 2 diabetes and incidence of a wide range of cardiovascular diseases： a cohort study in 1·9 million people［J］. Lancet， 2015， 385（）： S86.
[4]	KAMIL S， SEHESTED T S G， CARLSON N， et al. Diabetes and risk of peripheral artery disease in patients undergoing first-time coronary angiography between 2000 and 2012 - a nationwide study［J］. BMC Cardiovasc Disord， 2019， 19（1）： 234.
[5]	ANTZA C， KOSTOPOULOS G， MOSTAFA S， et al. The links between sleep duration， obesity and type 2 diabetes mellitus［J］. J Endocrinol， 2021， 252（2）： 125-141.
[6]	ROEVER L S， RESENDE E S， DINIZ A L， et al. Abdominal obesity and association with atherosclerosis risk factors： the uberlândia heart study［J］. Medicine， 2016， 95（11）： e1357.
[7]	KANG M K， SONG J E， KWEON Y O， et al. Visceral obesity and its association with severe coronary artery calcification in patients with metabolic dysfunction-associated steatotic liver disease［J］. Diagnostics （Basel）， 2024， 14（20）： 2305.
[8]	史云聪，郭艺芳. 2型糖尿病和动脉粥样硬化性心血管病的关系［J］. 心血管病学进展， 2020， 41（5）： 485-490.
[9]	LI J L， CHEN Y C， OU Z L， et al. Glucose-6-phosphate dehydrogenase deficiency and intracranial atherosclerotic stenosis in stroke patients［J］. Eur J Neurol， 2022， 29（9）： 2683-2689.
[10]	DORE M P， PORTOGHESE M， PES G M. The elderly with glucose-6-phosphate dehydrogenase deficiency are more susceptible to cardiovascular disease［J］. J Atheroscler Thromb， 2021， 28（6）： 604-610.
[11]	中华医学会糖尿病学分会.中国糖尿病防治指南（2024版）［J］.中华糖尿病杂志，2025，17（1）： 16-139.
[12]	中华医学会外科学分会血管外科学组. 下肢动脉硬化闭塞症诊治指南（下）［J/OL］. 中国血管外科杂志（电子版）， 2015， 7（4）： 229-238.
[13]	高永祥，张晋昕. Logistic回归分析的样本量确定［J］. 循证医学， 2018， 18（2）： 122-124.
[14]	中国医师协会超声医师分会. 血管超声检查指南［J］. 中华超声影像学杂志， 2009， 18（11）： 993-1012.
[15]	杨琴. 2型糖尿病患者血红蛋白与动脉粥样硬化相关性研究［D］. 泸州：西南医科大学， 2024.
[16]	BAI W Y， LI S S， LIANG T P， et al. The relationship between body mass index and peripheral artery disease： insights from the national health and nutrition examination survey and Mendelian randomization analysis［J］. J Surg Res， 2025， 306： 407-416.
[17]	XU X Y， WU H Y， WEI Q. Obesity-related indices as predictors of lower extremity arterial disease in type 2 diabetes mellitus［J］. Endocrine， 2025， 87（2）： 554-561.
[18]	AHMED B， SULTANA R， GREENE M W. Adipose tissue and insulin resistance in obese［J］. Biomed Pharmacother， 2021， 137： 111315.
[19]	CAI W M， XU J， WU X， et al. Association between triglyceride-glucose index and all-cause mortality in critically ill patients with ischemic stroke： analysis of the MIMIC-Ⅳ database［J］. Cardiovasc Diabetol， 2023， 22（1）： 138.
[20]	ROY P K， ISLAM J， LALHLENMAWIA H. Prospects of potential adipokines as therapeutic agents in obesity-linked atherogenic dyslipidemia and insulin resistance［J］. Egypt Heart J， 2023， 75（1）： 24.
[21]	HU H J， GARCIA-BARRIO M， JIANG Z S， et al. Roles of perivascular adipose tissue in hypertension and atherosclerosis［J］. Antioxid Redox Signal， 2021， 34（9）： 736-749.
[22]	HUANG Y， XU M， XIE L， et al. Obesity and peripheral arterial disease： a Mendelian Randomization analysis［J］. Atherosclerosis， 2016， 247： 218-224.
[23]	于辉，孙冠媛，丁悦. 超重/肥胖2型糖尿病病人动脉粥样硬化指数升高的危险因素及预警风险模型的建立［J］. 安徽医药， 2025， 29（10）： 2066-2070.
[24]	QIAO Y N， ZOU Y L， GUO S D. Low-density lipoprotein particles in atherosclerosis［J］. Front Physiol， 2022， 13： 931931.
[25]	TONG Y， XU S， HUANG L L， et al. Obesity and insulin resistance： Pathophysiology and treatment［J］. Drug Discov Today， 2022， 27（3）： 822-830.
[26]	付超，张静，董松武. 2型糖尿病病人脂代谢对心脏结构和功能的影响［J］. 安徽医药， 2021， 25（9）： 1735-1738.

Variable	Non-LEAD group (n=72)	LEAD group (n=197)	t/χ²/Z	P
Gender (n/%)
Male	44（61.1）	126（64.0）	0.184	0.668
Female	28（38.9）	71（36.0）
Age（year） [M(P25,P75)]	54（45，60）	60（54，66）	5.099	<0.001
Disease duration （year） [M(P25,P75)]	7.5（3.0，10.0）	10.0（6.5，17.0）	4.653	<0.001
BMI (x±s， kg·m^-2)	23.48±2.92	27.07±4.35	6.486	<0.001
Smoking (n/%)
Yes	23（31.9）	121（61.4）	18.418	<0.001
No	49（68.1）	76（38.6）
Hypertension (n/%)
Yes	20（27.8）	106（53.8）	14.347	<0.001
No	52（72.2）	91（46.2）
WBC [M(P25,P75)，×10⁹L^-1]	6.51（5.40，7.72）	6.52（5.65，7.80）	0.407	0.684
N [M(P25,P75)，×10⁹L^-1]	3.67（2.99，4.70）	3.78（3.24，4.65）	0.906	0.365
L [M(P25,P75)，×10⁹L^-1]	2.03（1.58，2.75）	2.06（1.65，2.55）	0.246	0.806
M [M(P25,P75)，×10⁹L^-1]	0.35（0.29，0.41）	0.36（0.28，0.43）	0.197	0.843
FBG [M(P25,P75)，mmol·L^-1]	8.49（7.05，11.43）	10.46（8.51，14.47）	3.926	<0.001
Cr (x±s，μmol·L^-1)	65.24±14.92	69.13±15.45	1.847	0.066
UA [M(P25,P75)，μmol·L^-1]	307.25（248.93，374.58）	329.00（278.35，394.20）	1.927	0.054
TG [M(P25,P75)，mmol·L^-1]	1.85（1.32，2.54）	2.26（1.51，3.23）	2.677	0.007
TC [M(P25,P75)，mmol·L^-1]	4.87（4.20，5.46）	5.02（4.36，5.09）	1.845	0.065
HDL-c [M(P25,P75)，mmol·L^-1]	1.16（1.01，1.34）	1.13（0.95，1.26）	1.796	0.072
LDL-c (x±s，mmol·L^-1)	2.49±0.70	2.63±0.81	1.315	0.190
HbAlc [M(P25,P75)，n/%]	8.05（7.30，10.88）	8.50（7.40，10.30）	0.340	0.734
C-P [M(P25,P75)，μg·L^-1]	2.48（1.93，3.11）	2.45（1.89，3.10）	0.287	0.774

Variable	Assignmented method
Dependent variable	0=Non-LEAD group； 1=LEAD group
Hypertension	0=No； 1=Yes
Gender	1=Male； 2=Female
Somking	0=No； 1=Yes

Variable	β	SE	Wald χ²	P	OR（95%CI）
Age	0.077	0.015	26.265	<0.001	1.080（1.048-1.112）
Disease duration	0.129	0.028	21.611	<0.001	1.138（1.077-1.201）
FBG	0.150	0.044	11.710	<0.001	1.162（1.066-1.266）
BMI	0.313	0.054	33.836	<0.001	1.367（1.230-1.519）
TG	0.345	0.131	6.925	0.008	1.412（1.092-1.826）
Smoking	1.221	0.292	17.487	<0.001	3.392（1.913-6.013）
Hypertension	1.108	0.299	13.696	<0.001	3.029（1.684-5.446）

Variable	β	SE	Wald χ²	P	OR（95%CI）
Age	0.079	0.021	14.778	<0.001	1.082（1.039-1.127）
BMI	0.253	0.056	20.613	<0.001	1.287（1.154-1.436）
FBG	0.148	0.054	7.537	0.006	1.159（1.043-1.288）
Disease duration	0.068	0.035	3.767	0.052	1.070（0.999-1.146）
TG	0.199	0.155	1.638	0.201	1.220（0.900-1.655）
Smoking	0.532	0.357	2.225	0.136	1.702（0.846-3.425）
Hypertension	0.354	0.370	0.914	0.339	1.424（0.690-2.939）

Analysis on influencing factors in type 2 diabetes mellitus patients complicated with lower limb atherosclerosis and construction of nomogram model

RichHTML

PDF (PC)

Like

Knowledge

Abstract

Cite this article

share this article

Figures/Tables 8

References 26

Related Articles 15

Metrics

Comments

Recommended 0

[1]	Shu LI,Jiaqi GUO,Wansong LI,Yanfeng ZHEN,Hongjia ZHAI,Jie LI,Hui FANG. Improvement effect of fingolimod on hepatic fibrosis in type 2 diabetes mellitus mice and its mechanism [J]. Journal of Jilin University(Medicine Edition), 2026, 52(2): 330-339.
[2]	Xiao LI,Li WANG,Wen WU,Rui WANG,Aiying ZHANG,Shuo ZHANG,Rujia JIANG,Yaning MENG. Clinical outcomes and risk factors analysis on infection in patients with bullous pemphigoid [J]. Journal of Jilin University(Medicine Edition), 2025, 51(5): 1312-1317.
[3]	Xiuzhen WEI,Yaling DONG,Zhibo ZHU,Zhengjie ZHANG,Yuanjun TAN,Jie BAI,Xiayi SU,Baihong ZHANG. Construction of prediction model for gastric cancer mismatch repair based on preoperative inflammatory indicators and clinicopathological features in gastric cancer patients [J]. Journal of Jilin University(Medicine Edition), 2025, 51(1): 172-181.
[4]	Weichao WU,Yan GUO,Xiangkai ZHAO,Zhiguang GU,Yijia GUO,Zipeng LAN,Hui HUANG,Lei KUANG,Ming ZHANG,Dongsheng HU,Yongli YANG,Wei WANG,Jinru CHEN. Correlation analysis on occupational acid fog exposure and accelerated biological aging in workers [J]. Journal of Jilin University(Medicine Edition), 2024, 50(6): 1741-1750.
[5]	Xiaopeng YU,Renyi YANG,Zuomei HE,Puhua ZENG. Establishment and validation of nomogram of cancer specific survival of patients with hepatocellular carcinoma with negative alpha fetoprotein based on SEER Database [J]. Journal of Jilin University(Medicine Edition), 2024, 50(1): 188-197.
[6]	Xue DONG, Jinfeng ZANG, Caifeng XU, Hebing LIU, Zhaohua CHENG. Construction and validation of risk prediction model of enteral nutrition feeding intolerance of patients with severe acute pancreatitis [J]. Journal of Jilin University(Medicine Edition), 2023, 49(6): 1586-1592.
[7]	Fang LIU,Jie ZHAO,Xiujuan CHEN,Saren WANG,Zeli TIAN,Shufang LI,Jing XI,Qin ZHANG. Effect of body mass index on pregnancy outcomes of patients with long regimen controlled ovarian hyperstimulation underwent fresh and freeze-thawed embryo transfer cycles [J]. Journal of Jilin University(Medicine Edition), 2023, 49(6): 1547-1553.
[8]	Jiaxin WANG,Zhenqi WANG,Xuan ZHANG. Expressions of CDKAL1 gene and its splice isomers in peripheral blood lymphocytes of patients with type 2 diabetes mellitus and their clinical significances [J]. Journal of Jilin University(Medicine Edition), 2023, 49(5): 1290-1295.
[9]	Xiaowei HUANG,Siqi ZHANG,Yixin ZHANG,Bo LIU,Xin WANG,Fenglan JI,Runze YANG,Huibo XU,Tao DING. Relationship between syndrome manifestations and differentially expressed genes in rat model of type 2 diabetes mellitus with Qi and Yin deficiency explored through transcriptomics [J]. Journal of Jilin University(Medicine Edition), 2023, 49(3): 625-633.
[10]	Jing GUAN,Shen HA,Hao YUAN,Ying CHEN,Pengju LIU,Zhi LIU,Shuang JIANG. Protective effect of Modified Xiao-Xian-Xiong Decoction on liver injury in rats with type 2 diabete mellitus and its mechanism [J]. Journal of Jilin University(Medicine Edition), 2023, 49(3): 608-616.
[11]	Junxiong ZHAO,Qian WU,Liangui NIE,Shengquan LIU,Zhentao JIANG,Jian CHEN,Ting XIAO,Jun YANG. Ameliorative effect of SO₂ on myocardial fibrosis in type 2 diabetes mellitus rats and its mechanism [J]. Journal of Jilin University(Medicine Edition), 2023, 49(1): 8-14.
[12]	Hong GAO,Xiaohong YAN,Li LIN,Lulu REN,Youzhu LI. Analysis of risk factors of late spontaneous abortion after assisted reproductive technology-assisted pregnancy [J]. Journal of Jilin University(Medicine Edition), 2022, 48(5): 1298-1304.
[13]	Yongxin ZHAI,Huaifeng TA,Yi ZHANG,Qijia SUN,Ming ZHANG,Shuqiang FENG,Ranwei LI. Effect of preoperative glycemic level on infection-related complications of diabetic patients after flexible ureteroscopic lithotripsy [J]. Journal of Jilin University(Medicine Edition), 2022, 48(3): 766-772.
[14]	Chengsheng LI,Qihan BAO,Xiaoyan HAO,Qingzhong PAN,Suzhen WANG,Fuyan SHI. Establishment of prediction model for postoperative pancreatic cancer based on random forest algorithm [J]. Journal of Jilin University(Medicine Edition), 2022, 48(2): 426-435.
[15]	LIU Donghui, FU Wenliang, FU Xiumei, SONG Chengjun, CHEN Zhihong. Regulatory effect of sericin on liver insulin PI3K/Akt signaling pathway in rats of type 2 diabetes mellitus and its mechanism [J]. Journal of Jilin University(Medicine Edition), 2020, 46(02): 228-232.